The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention*

Overview of attention for article published in Annual Review of Medicine, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 6 X users
patent: 19 patents

wikipedia: 2 Wikipedia pages
guideline: 2 clinical guideline sources

Readers on

mendeley: 1229 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 24,905 followers.

8) There are 4 #JAK family proteins (JAK1, JAK2, JAK3, and . . . wait for it . . . TYK2) plus 7 #STAT proteins that in aggregate cover the various #cytokine receptors. See 🔓https://t.co/d4eJnxXbsK. https://t.co/MXDi4vqlWq

The JAK-STAT Pathway: Will Oclacitinib, now K9 "APOQUEL", soon go to FDA HUMAN Trials/Market? Only Pfizer&FDA know! https://t.co/nLwln3rvqw

The therapeutic potential of inhibiting the Jak Stat pathway in disease #tofacitinib #arthritis #inflammation http://t.co/zQygl8pBLq

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.